I would be ecstatic to see CTIX get Prurisol into Phase 3 trials and Kevetrin into Phase 2 (which should happen around the same time) and then sell to Pfizer or whomever for $35-$50 a share. I know this is blasphemous to some . . . but, I would rather push the risk for FDA approval off on big pharma and take my money to my new beach house.